Comparison of efficacy of spironolactone with metformin in the management of polycystic ovary syndrome: An open-labeled study (vol 89, pg 2756, 2004)

被引:0
|
作者
Ganie, MA
Khurana, ML
Eunice, M
Gulati, M
Dwivedi, SN
Ammini, AC
机构
来源
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM | 2004年 / 89卷 / 09期
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:4655 / 4655
页数:1
相关论文
共 50 条
  • [41] Is plasminogen activator inhibitor-1 a cardiovascular risk factor in young women with polycystic ovary syndrome? (vol 9, pg 505, 2004)
    Orio, F
    Palomba, S
    Cascella, T
    Tauchmanovà, L
    Nardo, LG
    Di Biase, S
    Labella, D
    Russo, T
    Savastano, S
    Tolino, A
    Zullo, F
    Colao, A
    Lombardi, G
    REPRODUCTIVE BIOMEDICINE ONLINE, 2005, 10 (02) : 289 - 289
  • [42] Metformin Improves Glucose Effectiveness, Not Insulin Sensitivity: Predicting Treatment Response in Women With Polycystic Ovary Syndrome in an Open-Label, Interventional Study
    Pau, Cindy T.
    Keefe, Candace
    Duran, Jessica
    Welt, Corrine K.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2014, 99 (05): : 1870 - 1878
  • [43] Efficacy and safety of pioglitazone versus metformin in patients with type 2 diabetes mellitus:: A double-blind, randomized trial (vol 89, pg 6068, 2004)
    Schernthaner, G
    Matthews, DR
    Charbonnel, B
    Hanefeld, M
    Brunetti, P
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (02): : 746 - 746
  • [44] Effect of metformin pretreatment on pregnancy outcome of in vitro matured oocytes retrieved from women with polycystic ovary syndrome (Retraction of vol 90, pg 1149, 2008)
    Wei, Zhaolian
    Cao, Yunxia
    Cong, Lin
    Zhou, Ping
    Zhang, Zhiguo
    Li, Jun
    FERTILITY AND STERILITY, 2015, 104 (04) : 1048 - 1048
  • [45] Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome (vol 33, pg 1602, 2018)
    Teede, Helena J.
    Misso, Marie L.
    Costello, Michael F.
    Dokras, Anuja
    Laven, Joop
    Moran, Lisa
    Piltonen, Terhi
    Norman, Robert J.
    HUMAN REPRODUCTION, 2019, 34 (02) : 388 - 388
  • [46] Epidemiology, diagnosis and management of hirsutism: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome Society (vol 17, pg 438, 2011)
    Escobar-Morreale, H. F.
    Carmina, E.
    Dewailly, D.
    Gambineri, A.
    Kelestimur, F.
    Moghetti, P.
    Pugeat, M.
    Qiao, J.
    Wijeyaratne, C. N.
    Witchel, S. F.
    Norman, R. J.
    HUMAN REPRODUCTION UPDATE, 2013, 19 (02) : 207 - 207
  • [48] Open-Labeled, Randomized, Prospective Controlled Clinical Study to Assess Efficacy of Rasayana Churna and Pranayama in the Management of Rajonivritti Lakshanas w. s. r. to Postmenopausal Syndrome
    Ramugade, Divya
    Shitre, Ashwini
    INTERNATIONAL JOURNAL OF AYURVEDIC MEDICINE, 2022, 13 (04) : 952 - 956
  • [49] RETRACTION: Metformin versus laparoscopic ovarian drilling in clomiphene- and insulin- resistant women with polycystic ovary syndrome (vol 108, pg 143, 2010) (Retraction of Vol 108, Pg 143, 2010)
    Hamed, H. O.
    Hasan, A. F.
    Ahmed, O. G.
    Ahmed, M. A.
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2023, 162 (03) : 1127 - 1127
  • [50] Histomorphological Changes in a Rat Model of Polycystic Ovary Syndrome and the Contribution of Stevia Leaf Extract in Modulating the Ovarian Fibrosis, VEGF, and TGF-β Immunoexpressions: Comparison with Metformin (vol 55, pg 9, 2022)
    Morsi, Ahmed A.
    Mersal, Ezat A.
    Farrag, Abdel Razik H.
    Abdelmoneim, Ahmed M.
    Abdelmenem, Alshaymaa M.
    Salim, Mohamed S.
    ACTA HISTOCHEMICA ET CYTOCHEMICA, 2023, 56 (06)